Global Multiple Sclerosis Drugs Market Analysis 2013-2018 and Forecast 2019-2024

Publisher Name :
Date: 29-Apr-2019
No. of pages: 92

Summary

The global Multiple Sclerosis Drugs market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Multiple Sclerosis Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Oral

Injectable

Intravenous

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Biogen

Teva Pharmaceutical

Merck KGaA

Novartis

Bayer

Sanofi

Acorda Therapeutics

Questcor Pharmaceuticals

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Global Multiple Sclerosis Drugs Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview
1.1 Multiple Sclerosis Drugs Industry
1.1.1 Overview
1.1.2 Development of Multiple Sclerosis Drugs
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Multiple Sclerosis Drugs Market by Type
3.1 By Type
3.1.1 Oral
3.1.2 Injectable
3.1.3 Intravenous
3.2 Market Size
3.3 Market Forecast
4 Major Companies List
4.Multiple Sclerosis Drugs Biogen (Company Profile, Sales Data etc.)
4.2 Teva Pharmaceutical (Company Profile, Sales Data etc.)
4.3 Merck KGaA (Company Profile, Sales Data etc.)
4.4 Novartis (Company Profile, Sales Data etc.)
4.5 Bayer (Company Profile, Sales Data etc.)
4.6 Sanofi (Company Profile, Sales Data etc.)
4.7 Acorda Therapeutics (Company Profile, Sales Data etc.)
4.8 Questcor Pharmaceuticals (Company Profile, Sales Data etc.)
5 Market Competition
5.1 Company Competition
5.2 Regional Market by Company
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital Pharmacy
6.1.2 Demand in Retail Pharmacy
6.1.3 Demand in Online Pharmacy
6.2 Regional Demand Comparison
6.3 Demand Forecast
7 Region Operation
7.1 Regional Production
7.2 Regional Market
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
7.3.1.2 by Country (U.S., Canada, Mexico)
7.3.2 Europe
7.3.2.1 Overview
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
7.3.3 Asia-Pacific
7.3.3.1 Overview
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
7.3.4 South America
7.3.4.1 Overview
7.3.4.2 by Country (Brazil, Argentina etc.)
7.3.5 Middle East & Africa
7.3.5.1 Overview
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
9 Research Conclusion

List of Tables

Table Upstream Segment of Multiple Sclerosis Drugs
Table Application Segment of Multiple Sclerosis Drugs
Table Global Multiple Sclerosis Drugs Market 2013-2024, by Application, in USD Million
Table Major Company List of Oral
Table Major Company List of Injectable
Table Major Company List of Intravenous
Table Global Multiple Sclerosis Drugs Market 2013-2018, by Type, in USD Million
Table Global Multiple Sclerosis Drugs Market 2013-2018, by Type, in Volume
Table Global Multiple Sclerosis Drugs Market Forecast 2019-2024, by Type, in USD Million
Table Global Multiple Sclerosis Drugs Market Forecast 2019-2024, by Type, in Volume
Table Biogen Overview List
Table Multiple Sclerosis Drugs Business Operation of Biogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Overview List
Table Multiple Sclerosis Drugs Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck KGaA Overview List
Table Multiple Sclerosis Drugs Business Operation of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Multiple Sclerosis Drugs Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Overview List
Table Multiple Sclerosis Drugs Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Multiple Sclerosis Drugs Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Acorda Therapeutics Overview List
Table Multiple Sclerosis Drugs Business Operation of Acorda Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Questcor Pharmaceuticals Overview List
Table Multiple Sclerosis Drugs Business Operation of Questcor Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Multiple Sclerosis Drugs Sales Revenue 2013-2018, by Company, in USD Million
Table Global Multiple Sclerosis Drugs Sales Revenue Share, by Company, in USD Million
Table Global Multiple Sclerosis Drugs Sales Volume 2013-2018, by Company, in Volume
Table Global Multiple Sclerosis Drugs Sales Volume Share 2013-2018, by Company, in Volume
Table Major Consumers List and Overview
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Multiple Sclerosis Drugs Demand Forecast 2019-2024, by Application, in USD Million
Table Multiple Sclerosis Drugs Demand Forecast 2019-2024, by Application, in Volume
Table Multiple Sclerosis Drugs Production 2013-2018, by Region, in USD Million
Table Multiple Sclerosis Drugs Production 2013-2018, by Region, in Volume
Table Global Multiple Sclerosis Drugs Market 2013-2018, by Region, in USD Million
Table Global Multiple Sclerosis Drugs Market Share 2013-2018, by Region, in USD Million
Table Global Multiple Sclerosis Drugs Market 2013-2018, by Region, in Volume
Table Global Multiple Sclerosis Drugs Market Share 2013-2018, by Region, in Volume
Table North America Multiple Sclerosis Drugs Market Size 2013-2018, by Country, in USD Million
Table North America Multiple Sclerosis Drugs Market Size 2013-2018, by Country, in Volume
Table Europe Multiple Sclerosis Drugs Market Size 2013-2018, by Country, in USD Million
Table Europe Multiple Sclerosis Drugs Market Size 2013-2018, by Country, in Volume
Table Asia-Pacific Multiple Sclerosis Drugs Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Multiple Sclerosis Drugs Market Size 2013-2018, by Country, in Volume
Table South America Multiple Sclerosis Drugs Market Size 2013-2018, by Country, in USD Million
Table South America Multiple Sclerosis Drugs Market Size 2013-2018, by Country, in Volume
Table Middle East & Africa Multiple Sclerosis Drugs Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Multiple Sclerosis Drugs Market Size 2013-2018, by Country, in Volume
Table Multiple Sclerosis Drugs Market Forecast 2019-2024, by Region, in USD Million
Table Multiple Sclerosis Drugs Market Forecast 2019-2024, by Region, in Volume
Table Price Factors List

List of Figures

Figure Global Multiple Sclerosis Drugs Market Growth 2013-2018, by Type, in USD Million
Figure Global Multiple Sclerosis Drugs Market Growth 2013-2018, by Type, in Volume
Figure North America Multiple Sclerosis Drugs Market Concentration, in 2018
Figure Europe Multiple Sclerosis Drugs Market Market Concentration, in 2018
Figure Asia-Pacific Multiple Sclerosis Drugs MMarket Concentration, in 2018
Figure South America Multiple Sclerosis Drugs Market Concentration, in 2018
Figure Middle East & Africa Multiple Sclerosis Drugs Market Concentration, in 2018
Figure Multiple Sclerosis Drugs Demand in Hospital Pharmacy , 2013-2018, in USD Million
Figure Multiple Sclerosis Drugs Demand in Hospital Pharmacy , 2013-2018, in Volume
Figure Multiple Sclerosis Drugs Demand in Retail Pharmacy , 2013-2018, in USD Million
Figure Multiple Sclerosis Drugs Demand in Retail Pharmacy , 2013-2018, in Volume
Figure Multiple Sclerosis Drugs Demand in Online Pharmacy, 2013-2018, in USD Million
Figure Multiple Sclerosis Drugs Demand in Online Pharmacy, 2013-2018, in Volume
Figure North America Multiple Sclerosis Drugs Market Size and Growth 2013-2018, in USD Million
Figure North America Multiple Sclerosis Drugs Market Size and Growth 2013-2018, in Volume
Figure Europe Multiple Sclerosis Drugs Market Size and Growth 2013-2018, in USD Million
Figure Europe Multiple Sclerosis Drugs Market Size and Growth 2013-2018, in Volume
Figure Asia-Pacific Multiple Sclerosis Drugs Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Multiple Sclerosis Drugs Market Size and Growth 2013-2018, in Volume
Figure South America Multiple Sclerosis Drugs Market Size and Growth 2013-2018, in USD Million
Figure South America Multiple Sclerosis Drugs Market Size and Growth 2013-2018, in Volume
Figure Middle East & Africa Multiple Sclerosis Drugs Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Multiple Sclerosis Drugs Market Size and Growth 2013-2018, in Volume
Figure Marketing Channels Overview
  • Global Multiple Sclerosis Drugs Sales Market Report 2021
    Published: 19-Apr-2021        Price: US 4000 Onwards        Pages: 120
    The global Multiple Sclerosis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Sclerosis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Injectable Medications - Or......
  • 2020-2025 Global Multiple Sclerosis Drugs Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 01-Apr-2021        Price: US 3360 Onwards        Pages: 112
    Multiple sclerosis (MS) is the most common disabling neurological disease in young people worldwide. This report elaborates the market size, market characteristics, and market growth of the Multiple Sclerosis Drugs industry, and breaks down according to the type, application, and consumption area of Multiple Sclerosis Drugs. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of......
  • Global Multiple Sclerosis Drugs Market Analysis 2016-2020 and Forecast 2021-2026
    Published: 24-Mar-2021        Price: US 2980 Onwards        Pages: 79
    Snapshot The global Multiple Sclerosis Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Multiple Sclerosis Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors ......
  • Global Multiple Sclerosis Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 16-Mar-2021        Price: US 3500 Onwards        Pages: 113
    Multiple sclerosis (MS) is a chronic inflammatory neuropathy characterized by demyelination, axonal transection, and neurodegeneration in the central nervous system. Based on the Multiple Sclerosis market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types ......
  • Global Multiple Sclerosis Drugs Market Research Report 2021
    Published: 14-Jan-2021        Price: US 2900 Onwards        Pages: 91
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Injectable Medications - Oral Medications - Others Segment by Application - Adults......
  • Global Fingolimod Market Research Report 2021, Forecast to 2026
    Published: 13-Jan-2021        Price: US 2680 Onwards        Pages: 132
    The report forecast global Fingolimod market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively." The report demonstrates detail coverage of Fingolimod industry and......
  • Global Fingolimod Professional Survey Report 2021, Forecast to 2026
    Published: 13-Jan-2021        Price: US 3280 Onwards        Pages: 103
    The report forecast global Fingolimod market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively." The report demonstrates detail coverage of Fingolimod industry and......
  • Global Fingolimod Market Research Report 2021
    Published: 04-Jan-2021        Price: US 2900 Onwards        Pages: 91
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Oral - Injection Segment by Application - Medical Field - Science Research Field......
  • Multiple Sclerosis Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
    Published: 21-Dec-2020        Price: US 3000 Onwards        Pages: 88
    Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmen......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs